Literature DB >> 11258411

Ictal ECD-SPECT differentiates between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure control.

S Weil1, S Noachtar, S Arnold, T A Yousry, P A Winkler, K Tatsch.   

Abstract

We investigated whether ictal single photon emission computed tomography (SPECT) with 99Tcm-ethyl cysteinate dimer (ECD) could differentiate between temporal (TE) and extratemporal epilepsy (ETE) in 30 consecutive patients (n = 21 for TE, n = 9 for ETE), all of whom had excellent postoperative seizure control (class I according to Engel's classification). Ictal SPECT showed isolated temporal hyperperfusion in 90% (19 out of 21) of the TE patients and normal perfusion in two patients. All the ETE patients had ictal SPECT findings consistent with extratemporal seizure onset. The sensitivity of ictal ECD-SPECT for correct localization of the seizure onset zone was 80% in all patients, 86% in TE patients and 66% in ETE patients. Although ictal ECD-SPECT has a lower sensitivity in ETE than in TE, it can be used to clearly distinguish between TE and ETE. It provides non-invasive imaging information for use in further diagnostic and treatment strategies in patients with drug-resistant focal epilepsy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11258411     DOI: 10.1097/00006231-200102000-00016

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  14 in total

1.  [Neuroimaging of epilepsies].

Authors:  C Vollmar; C la Fougère
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

2.  A Novel method of seizure onset zone localization by serial Tc-99 m ECD brain perfusion SPECT clearance patterns.

Authors:  Chanan Sukprakun; Chusak Limotai; Kitiwat Khamwan; Panya Pasawang; Supatporn Tepmongkol
Journal:  Brain Imaging Behav       Date:  2022-02-23       Impact factor: 3.224

Review 3.  A review of diagnostic techniques in the differential diagnosis of epileptic and nonepileptic seizures.

Authors:  Dona E Cragar; David T R Berry; Toufic A Fakhoury; Jean E Cibula; Frederick A Schmitt
Journal:  Neuropsychol Rev       Date:  2002-03       Impact factor: 7.444

4.  Seizure onset zone localization using postictal hypoperfusion detected by arterial spin labelling MRI.

Authors:  Ismael Gaxiola-Valdez; Shaily Singh; Tefani Perera; Sherry Sandy; Emmy Li; Paolo Federico
Journal:  Brain       Date:  2017-11-01       Impact factor: 13.501

5.  Statistical SPECT processing in MRI-negative epilepsy surgery.

Authors:  Vlastimil Sulc; Samantha Stykel; Dennis P Hanson; Benjamin H Brinkmann; David T Jones; David R Holmes; Richard A Robb; Matthew L Senjem; Brian P Mullan; Robert E Watson; Daniel Horinek; Gregory D Cascino; Lily C Wong-Kisiel; Jeffrey W Britton; Elson L So; Gregory A Worrell
Journal:  Neurology       Date:  2014-02-14       Impact factor: 9.910

Review 6.  PET studies in epilepsy.

Authors:  Ismet Sarikaya
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

7.  Role of single photon emission computed tomography in epilepsy.

Authors:  Sita Jayalakshmi; Pushpalatha Sudhakar; Manas Panigrahi
Journal:  Int J Mol Imaging       Date:  2010-12-14

8.  Functional neuro-imaging as a pre-surgical tool in epilepsy.

Authors:  Zulfi Haneef; David K Chen
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

Review 9.  (18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy.

Authors:  Marina Hodolic; Raffi Topakian; Robert Pichler
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

10.  Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling.

Authors:  Ilaria Boscolo Galazzo; Maria Vittoria Mattoli; Francesca Benedetta Pizzini; Enrico De Vita; Anna Barnes; John S Duncan; Hans Rolf Jäger; Xavier Golay; Jamshed B Bomanji; Matthias Koepp; Ashley M Groves; Francesco Fraioli
Journal:  Neuroimage Clin       Date:  2016-04-12       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.